Clinical Trial Update: Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pharmacodynamic effects of switching from ticagrelor to prasugrel in patients with stable coronary artery disease; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2014-04-29